Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Calcipotriol.
Alfacalcidol
The risk or severity of adverse effects can be increased when Calcipotriol is combined with Alfacalcidol.
Aluminum Hydroxide
The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcipotriol.
Advertisement
aluminum hydroxide, dried (USP)
The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcipotriol.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Calcipotriol.
Bendroflumethiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Bendroflumethiazide.
Advertisement
Benzthiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Benzthiazide.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Calcipotriol.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Calcipotriol.
Advertisement
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Calcipotriol.
Calcifediol
The risk or severity of adverse effects can be increased when Calcidiol is combined with Calcipotriol.
Calcifediol Anhydrous
The risk or severity of adverse effects can be increased when Calcidiol is combined with Calcipotriol.
Calcitriol
The risk or severity of adverse effects can be increased when Calcipotriol is combined with Calcitriol.
Calcium Acetate
The risk or severity of adverse effects can be increased when Calcium Acetate is combined with Calcipotriol.
Calcium Carbonate
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Calcipotriol.
CALCIUM CARBONATE, PRECIPITATED
The risk or severity of adverse effects can be increased when Calcium Carbonate is combined with Calcipotriol.
Calcium Chloride
The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Calcipotriol.
Calcium Chloride Anhydrous
The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Calcipotriol.
Calcium Citrate
The risk or severity of adverse effects can be increased when Calcium Citrate is combined with Calcipotriol.
Calcium Glubionate
The risk or severity of adverse effects can be increased when Calcium glubionate is combined with Calcipotriol.
Calcium gluceptate
The risk or severity of adverse effects can be increased when Calcium Gluceptate is combined with Calcipotriol.
Calcium Gluconate
The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Calcipotriol.
Calcium Lactate
The risk or severity of adverse effects can be increased when Calcium lactate is combined with Calcipotriol.
CALCIUM LEVULINATE
The risk or severity of adverse effects can be increased when Calcium levulinate is combined with Calcipotriol.
Casein Allergenic Extract
The risk or severity of adverse effects can be increased when Casein is combined with Calcipotriol.
Chlorothiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Chlorothiazide.
Chlorthalidone
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Chlorthalidone.
Cholecalciferol
The risk or severity of adverse effects can be increased when Calcipotriol is combined with Cholecalciferol.
Cholestyramine Resin
The serum concentration of Calcipotriol can be decreased when it is combined with Cholestyramine.
Colesevelam
The serum concentration of Calcipotriol can be decreased when it is combined with Colesevelam.
Colestipol
The serum concentration of Calcipotriol can be decreased when it is combined with Colestipol.
Cyclopenthiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Cyclopenthiazide.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Calcipotriol.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Calcipotriol.
Danazol
Danazol may increase the hypercalcemic activities of Calcipotriol.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Calcipotriol.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Calcipotriol.
Digoxin
Digoxin may decrease the cardiotoxic activities of Calcipotriol.
Dihydrotachysterol
The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcipotriol.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Calcipotriol.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Calcipotriol.
Doxercalciferol
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcipotriol.
Ergocalciferol
The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Calcipotriol.
Heavy mineral oil
The serum concentration of Calcipotriol can be decreased when it is combined with Mineral oil.
Hydrochlorothiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Hydrochlorothiazide.
Hydroflumethiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Hydroflumethiazide.
Indapamide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Indapamide.
Methyclothiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Methyclothiazide.
Metolazone
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Metolazone.
Mineral Oil
The serum concentration of Calcipotriol can be decreased when it is combined with Mineral oil.
Orlistat
The serum concentration of Calcipotriol can be decreased when it is combined with Orlistat.
Ouabain
Ouabain may decrease the cardiotoxic activities of Calcipotriol.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Calcipotriol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Calcipotriol.
Paricalcitol
The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcipotriol.
Polythiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Polythiazide.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Calcipotriol.
Quinethazone
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Quinethazone.
Sucralfate
The serum concentration of Sucralfate can be increased when it is combined with Calcipotriol.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Calcipotriol.
Tricalcium Phosphate
The risk or severity of adverse effects can be increased when Calcium Phosphate is combined with Calcipotriol.
Trichlormethiazide
The risk or severity of hyperkalemia can be increased when Calcipotriol is combined with Trichlormethiazide.